AlgiPharma AS
PrivateLast Round
Grant
Dec 20, 2021
Total Funding Raised
$23.57M
Company Overview
AlgiPharma AS is a biopharmaceutical company that develops proprietary alginate technology for drug delivery platforms, drug conjugates, and therapeutic applications in areas such as cystic fibrosis, COPD, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgiPharma AS Comparables
Compare AlgiPharma AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renovion, Inc. | 82% | |
| Enterprise Therapeutics | 80% | |
| Aer Therapeutics | 77% | |
AlgiPharma AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2021 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
Grant | Jun 3, 2016 |
AlgiPharma AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovasjon Norge | Grant |
| European Union's Horizon 2020 | Grant |
| Cystic Fibrosis Foundation | Grant |
| Innovate UK | Grant |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 226% MoM, reaching 2.7K.
- Jun 1, 2025
Monthly visitors increased 912% MoM, reaching 1.7K.
AlgiPharma AS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AlgiPharma AS's valuation, stock price, and market status.